SSAT Home  |  Past Meetings
Society for Surgery of the Alimentary Tract

Program and Abstracts

61st Annual Meeting
SOCIETY FOR SURGERY OF THE ALIMENTARY TRACT
May 2-5, 2020
McCormick Place - Chicago, IL
in partnership with Digestive Disease Week®


Program (Subject to Change)

All rooms at McCormick Place unless otherwise indicated.

<<Monday | Program and Abstracts

Ticketed Session indicates a Ticketed Session requiring a separate registration and fee.
Plenary presentation indicates a Plenary presentation that is also being presented at the Residents & Fellows Research Conference; participation in and attendance at this conference is by invitation only.
Tracks
Esophagus, Gastric, Bariatric, & Metabolic GI Tract
Hepatobiliary & Pancreas Education, Quality, Outcomes, & Policy
Small Bowel, Abdominal Wall, Hernia, & Colorectal General & Society Business

TUESDAY, May 5, 2020
6:30 AM - 7:45 AM
S405
Ticketed Session BREAKFAST CONNECTIONS:
EMERGENCY SURGERY IN THE IBD PATIENT
 
Melanie Morris, Birmingham, AL
David B. Stewart, Tucson, AZ
7:30 AM - 9:30 AM
S105a
SSAT/ISDS SYMPOSIUM:
GLOBAL SURGERY: THE BEST OF BOTH WORLDS
 
Moderators: Michael F. McGee, Chicago, IL
Alessandro Fichera, Dallas, TX

HOW TO BUILD A SUSTAINABLE OUTREACH PROGRAM
Anthony G. Charles, Chapel Hill, NC

HOW TO BUILD A HOMEGROWN PROGRAM
April Roslani, Kuala Lumpur, Malaysia

WHAT CAN I ACCOMPLISH ON MY OWN
Rebecca Weddle, Dallas, TX

DEVELOPING NCCN GUIDELINES FOR NATIONAL RECTAL CANCER CARE IN BOLIVIA
Steven J. Schuetz, Chicago, IL
7:30 AM - 9:00 AM
S105bc
PLENARY SESSION: HEPATOBILIARY & PANCREAS II
890.
TGF-β RECEPTOR INHIBITION INCREASES PD-L1 EXPRESSION IN PANCREATIC CANCER
Marcus A. Alvarez*, Syed M. Hussain, Rita G. Kansal, Leah Hendrick, Paxton Dickson, Jeremiah Deneve, David Shibata, Evan S. Glazer
Surgery, University of Tennessee Health Science Center, Memphis, TN
891.
DUCTULAR PROLIFERATION AND FIBROSIS AS INDICATORS OF HEPATIC FAILURE IN PATIENTS WITH BILE DUCT INJURY
Patricio R. Sanchez Fernandez*1,2,3
1Gastrointestinal Surgery, Instituto Mexicano del Seguro Social-Universidad Nacional Autónoma de México, Mexico City, Mexico City, Mexico; 2American College of Surgeons, Mexico City, Mexico City, Mexico; 3Academia Mexicana de Cirugia, Mexico City, Mexico City, Mexico
892.
PORTAL VEIN THROMBOSIS AFTER VENOUS RECONSTRUCTION DURING PANCREATECTOMY: TIMING AND RISKS
Alexandra M. Roch*, E M. Kilbane, Trang K. Nguyen, Eugene P. Ceppa, Nicholas J. Zyromski, C. Max Schmidt, Attila Nakeeb, Michael G. House
Indiana University School of Medicine, Indianapolis, IN
893.
LAPAROSCOPIC ASSISTED ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY FOLLOWING GASTRIC BYPASS: A 12-YEAR ASSESSMENT OF OUTCOMES AND LEARNING CURVE AT A HIGH VOLUME PANCREATOBILIARY CENTER
Samer S. Al Masri*1, Mazen S. Zenati1, Georgios Papachristou1, Adam Slivka1, Jennifer Chennat1, Mordechai Rabinovitz1, Asif Khalid1, Andres Gelrud7, John Y. Nasr2, Savreet Sarkaria1, Rohit Das1, Kenneth Lee1, Wolfgang H. Schraut1, Steven J. Hughes3, A. J. Moser4, Alessandro Paniccia1, Melissa E. Hogg5, Herbert J. Zeh6, Amer H. Zureikat1
1Surgical Oncology, Unviersity of Pittsburgh Medical Center, Pittsburgh, PA; 2WVU Hospital, Morgantown, WV; 3UF Health, Gainesville, FL; 4Beth Israel Deaconess Medical Center, Boston, MA; 5NorthShore HealthSystem, Evanston, IL; 6UT Southwestern Medical Center, Dallas, TX; 7Gastro Health, Miami, FL
894.
OUTCOMES WITH PREOPERATIVE BILIARY STENTING AFTER PANCREATICODUODENECTOMY IN THE MODERN ERA
Mohammad Khreiss, Jacqueline Dauch*, Catherine OGrady, Chiu-Hsieh Hsu, Amanda Arrington, Taylor S. Riall
University of Arizona College of Medicine - Tucson, Tucson, AZ
895.
REDUCTION OF INTRAPERITONEAL ADHESIOGENESIS BY PROTEASE INHIBITORS IN A CECAL LIGATION AND PUNCTURE MODEL OF SEPSIS AND PERITONITIS.
Philip Plaeke*1, Joris De Man1, Annemieke Smet1, Ingrid De Meester1, Koen Augustyns1, Philippe Jorens1,2, Guy Hubens1,2, Benedicte Y. De Winter1
1University of Antwerp, Wilrijk, Antwerp, Belgium; 2Antwerp University Hospital, Edegem, Antwerp, Antwerp, Belgium
8:00 AM - 9:30 AM
S105d
QUICK SHOT SESSION: SMALL BOWEL, ABDOMINAL WALL, HERNIA, & COLORECTAL II
896.
TIMELY COORDINATION AND TREATMENT FOR COLORECTAL CANCERS DIAGNOSED IN THE EMERGENCY DEPARTMENT
Vanessa Arientyl*, Patricia Friedmann, DAVID WEITHORN, Haejin In
Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
897.
RISK-STRATIFIED COMPARISON OF BRIDGE TO SURGERY APPROACHES VERSUS EMERGENCY RESECTION IN PATIENTS WITH LEFT-SIDED OBSTRUCTIVE COLON CANCER: A NATIONWIDE STUDY
Joyce Veld*1, Femke J. Amelung2,3, Wernard Borstlap1, Emo E. van Halsema1, Esther Consten3,4, Peter D. Siersema5, Frank ter Borg6, Edwin van der zaag7, Paul Fockens1, Willem A. Bemelman1, Jeanin E. Van Hooft1, Pieter J. Tanis1
1Amsterdam UMC, University of Amsterdam, Weesp, Netherlands; 2University Medical Center Utrecht, Utrecht, Netherlands; 3Meander Medical Center, Amersfoort, Netherlands; 4University Medical Center Groningen, Groningen, Netherlands; 5Radboud University Medical Center, Nijmegen, Netherlands; 6Deventer Ziekenhuis, Deventer, Netherlands; 7Gelre hospital, Apeldoorn, Netherlands
898.
DEVELOPMENT OF BLOOD-BASED, CANCER-ASSOCIATED BIOMARKERS FOR EARLY DETECTION OF COLORECTAL CANCER: SIGNIFICANT DIFFERENCES BETWEEN RESULTS FROM SYMPTOMATIC AND SCREENING SUBJECTS.
Jakob Kleif1, Linnea Ferm1, Gerard J. Davis2, Ib J. Christensen1, Hans J. Nielsen*1
1Surgical Gastroenterology, Hvidovre University Hospital, Hvidovre, Danmark, Denmark; 2Abbott Laboratories, Abbott Park, IL
899.
EARLY DETECTION OF COLORECTAL NEOPLASIA: APPLICATION OF A BLOOD-BASED SEROLOGICAL PROTEIN TEST ON SUBJECTS UNDERGOING POPULATION-BASED SCREENING.
Jakob Kleif*1, Lars N. Jørgensen2,3, Jakob Hendel4, Mogens R. Madsen5, Jesper Vilandt6, Søren Brandsborg7, Ali Khalid8, Linnea Ferm1, Gerard J. Davis9, Susan H. Gawel9, Frans Martens10, Ib J. Christensen1, Hans J. Nielsen1,3
1Hvidovre Hospital - Copenhagen - Denmark, Hvidovre, Denmark; 2Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; 3Copenhagen University, Copenhagen, Denmark; 4Herlev and Gentofte University Hospital, Herlev, Denmark; 5Herning Hospital, Herning, Denmark; 6Nordsjaellands Hospital, Hillerød, Denmark; 7Horsens Hospital, Horsens, Denmark; 8Viborg Hospital, Viborg, Denmark; 9Abbott Laboratories, Abbott park, IL, IL; 10Amsterdam Medical Center, Amsterdam, Netherlands
900.
SOCIODEMOGRAPHIC DISPARITIES AND SURVIVAL IMPLICATIONS OF REFUSAL OF SURGERY AMONG U.S. PATIENTS WITH RESECTABLE COLON CANCER: AN NCDB COHORT ANALYSIS, 2004 - 2016
Isaac G. Alty*1, Edward C. Dee1, Lawrence S. Blaszkowsky2, Jennifer Y. Wo2, Motaz Qadan2
1Harvard Medical School, Brookline, MA; 2Newton-Wellesley Hospital, Newton, MA
901.
IMPROVING MOTHER NATURE: ENHANCED ANTICANCER ACTIVITY DEMONSTRATED BY STRUCTURAL VARIANTS OF CURCUMIN
Bryant Megna*1, Patrick Carney3, Rhonda Rosengren4, Gregory D. Kennedy2
1Medicine, University of Minnesota Medical Center, Minneapolis, MN; 2University of Alabama at Birmingham School of Medicine, Birmingham, AL; 3University of Wisconsin School of Medicine and Public Health, Madison, WI; 4University of Otago, Otago, Otago, New Zealand
902.
A TALE OF TWO CANCERS: DO LYMPH NODE RESECTIONS TRULY MEAN THE SAME IN COLON AND RECTAL CANCERS?
Amanda Arrington*, Catherine OGrady, Mohammad Khreiss, Taylor S. Riall
University of Arizona, Tucson, AZ
903.
ROLE OF INTERLEUKIN 10 GENETIC POLYMORPHISMS IN RECTAL CANCER PATIENTS
Jorge Luis de León Rendón*, Raquel Yazmin López Pérez, Juan A. Villanueva-Herrero, Noé Isaías Gracida Mancilla, Billy Jiménez Bobadilla
Coloproctology , Hospital General de Mexico "Dr. Eduardo Liceaga", Mexico, CDMX, Mexico
904.
WHEN IS DIVERSION INDICATED AFTER RIGHT SIDED COLON RESECTION?
Nicholas P. McKenna*, Katherine Bews, Kellie L. Mathis, Elizabeth B. Habermann
General Surgery, Mayo Clinic , Rochester, MN
905.
PAX6: A POTENTIAL EPIGENETICALLY-REGULATED TUMOR SUPPRESSOR IN HPV-ASSOCIATED CANCERS
Denise Wong*, Abul Elahi, Leah Hendrick, Abidemi Ajidahun, Syed M. Hussain, Irina Getun, Rita G. Kansal, Evan S. Glazer, David Shibata
University of Tennessee Health Science Center, Memphis, TN
906.
LYMPHOCYTE-WHITE CELL COUNT RATIO AS A NOVEL MARKER OF MORBIDITY IN PATIENTS UNDERGOING ELECTIVE SURGERY FOR COLORECTAL CANCER
Jia Jun Ang*, Daryl K. Chia, Dedrick Kok Hong Chan
National University Health System (NUHS), Singapore, Singapore
907.
THE IMPACT OF POST-SURGICAL COMPLICATIONS ON LONG TERM ONCOLOGICAL OUTCOMES FOLLOWING CURATIVE RESECTION OF COLORECTAL CANCER (STAGE I-III). A SYSTEMATIC REVIEW AND META-ANALYSIS.
Noor Mualla1, Maryam R Hussain*1, Muhammad Akrmah2
1Graduate School, Icahn School of Medicine at Mount Sinai, New York, NY; 2Hartford Hospital/University of Connecticut Health Center, Hartford, CT
908.
TOTAL NEOADJUVANT THERAPY VERSUS NEOADJUVANTCHEMORADIATION IN PATIENTS WITH STAGE II-III RECTAL CANCER: IMPACT ON PATHOLOGIC COMPLETE RESPONSE, TUMOR DOWNSTAGING, AND SURVIVAL RATES.
Paolo Goffredo*1, Adil Khan2, Sarah Bell1, Xiang Gao1, Kyle Freischlag1, Pashtoon M. Kasi1, Y. Nancy You3, Imran Hassan1
1Surgery, University of Iowa, Iowa City, IA; 2Raleigh General Hospital, Beckley, WV; 3MD Anderson Cancer Center, Huston, TX
909.
DEVELOPMENT OF BLOOD-BASED BIOMARKER TESTS FOR EARLY DETECTION OF COLORECTAL NEOPLASIA: INFLUENCE OF BLOOD COLLECTION TIMING AND HANDLING PROCEDURES
Mathias M. Petersen*1, Hans J. Nielsen2, Niels L. Pedersen2, Jon J. Ladd4, Paul D. Lampe4, Robert S. Bresalier5, Gerard J. Davis6, Christina Demuth3, Claus L. Andersen3, Sarah Ø. Jensen3, Linnea Ferm2, Ib J. Christensen2
1Gastrounit 360 - Surgical Department, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark; 2Hvidovre University Hospital, Hvidovre, Denmark; 3Department of Molecular Medicine, Skejby, Denmark; 4Fred Hutchinson Cancer Research Center, Seattle, WA; 5MD Anderson Cancer Center, Houston, TX; 6Abbott Laboratories, Abbott Park, IL
910.
SEROLOGICAL CANCER-ASSOCIATED PROTEIN BIOMARKER LEVELS AT NEGATIVE BOWEL ENDOSCOPY; INCREASED RISK OF SUBSEQUENT PRIMARY MALIGNANCY?
Thomas B. Piper*, Ib J. Christensen, Linnea Ferm, Hans J. Nielsen
Department of Surgical Gastroenterology, Hvidovre Hospital - Copenhagen - Denmark, Hvidovre, Copenhagen, Denmark
10:00 AM - 11:30 AM
S105a
PLENARY SESSION: ESOPHAGUS, GASTRIC, BARIATRIC, & METABOLIC II
1035.
GASTRIC BYPASS INCREASES CIRCULATING BILE ACIDS AND ACTIVATES HEPATIC FARNESOID X RECEPTOR (FXR), BUT REQUIRES INTACT PEROXISOME PROLIFERATOR ACTIVATOR RECEPTOR ALPHA (PPAR-A) SIGNALING TO REDUCE LIVER FAT CONTENT.
Guilherme d. Mazzini*, Jad Khoraki, Matthew G. Browning, Yahya Alwatari, Jilin Wu, Huiping Zhou, Guilherme M. Campos
Virginia Commonwealth University, Richmond, VA
1036.
OESOPHAGO-GASTRIC TRANSIT FOLLOWING SLEEVE GASTRECTOMY: MECHANISM OF RAPID GASTRIC EMPTYING
Yazmin Johari*1,2, Anagi Wickremasinghe1, Gilian Lim1, Helen Yue2, Geraldine Ooi1,2, Cheryl Laurie1, Geoffrey Hebbard3, Paul Beech2, Paul Burton1,2, Wendy Brown1,2
1Monash University, Melbourne, Victoria, Australia; 2Alfred Health, Melbourne, Victoria, Australia; 3Royal Melbourne Hospital, Melbourne, Victoria, Australia
1037.
GASTROJEJUNAL ANASTOMOTIC STENOSIS: A MATCHED COHORT STUDY COMPARING EFFICACY AND SAFETY OF LUMEN-APPOSING METAL STENT PLACEMENT TO STANDARD BALLOON DILATION
Kelly Hathorn*1, Pedro Cortés2, Thomas R. McCarty1, Thomas J. Wang3, Ahmad Najdat Bazarbashi1, Marvin Ryou1, Walter W. Chan1, Christopher C. Thompson1
1Brigham & Women's Hospital, Boston, MA; 2Harvard Medical School, Boston, MA; 3Massachusetts General Hospital, Boston, MA
1038.
LONG-TERM OUTCOMES OF ROUX-EN-Y GASTRIC DIVERSION AFTER FAILED SURGICAL FUNDOPLICATION IN A LARGE COHORT
Veeravich Jaruvongvanich*, Reem Matar, Blake Movitz, Daniel B. Maselli, Travis J. McKenzie, Todd A. Kellogg, Michael L. Kendrick, Barham K. Abu Dayyeh
Gastroenterology, Mayo Clinic - Rochester, Rochester, MN
1039.
REDO FUNDOPLICATION AND ROUX-EN-Y DIVERSION FOR FAILED FUNDOPLICATION: A 3-YEARS SINGLE-CENTER EXPERIENCE
Luca Giulini*1,2, Deepika Razia1,2, Sumeet Mittal1,2,3
1St. Joseph’s Hospital and Medical Center, Phoenix, AZ; 2Norton Thoracic Institute, St Joseph’s Hospital and Medical Center, Dignity Health, Phoenix, AZ; 3Creighton University St. Joseph's Hospital and Medical Center, Phoenix, AZ
1040.
PATIENT REMOTENESS FROM URBAN CENTRE DOES NOT IMPACT GASTRIC CANCER OUTCOMES IN THE CONTEXT OF AN ESTABLISHED CARE CORRIDOR TO A SPECIALIST MULTIDISCIPLINARY CANCER CENTRE
Anitha Kammili*, Dominique Morency, Kyle Zullo, Saleh Almatar, Lina Abdrabo, Aya Siblini, Jonathan Cools-Lartigue, Lorenzo E. Ferri, Carmen L. Mueller
Thoracic and Upper Gastrointestinal Surgery, McGill University Health Center, Montreal, QC, Canada
10:00 AM - 11:30 AM
S105bc
PLENARY SESSION: SMALL BOWEL, ABDOMINAL WALL, HERNIA, & COLORECTAL II
1041.
DEVELOPMENT OF A NOMOGRAM TO PREDICT INDIVIDUAL BENEFIT ATTAINED FROM ADDITION OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF STAGE II COLON CANCER
Clay M. Merritt*1, Shu-Ching Chang2, Gary L. Grunkemeier2, Scott Steele4, Melanie Goldfarb3, Daniel Nelson1
1Surgery, William Beaumont Army Medical Center, El Paso, TX; 2Medical Data Research Center, Providence St. Joseph Health, Portland, OR; 3John Wayne Cancer Institute, Santa Monica, CA; 4Cleveland Clinic, Cleveland, OH
1042.
PROGNOSTIC IMPACT AND UTILITY OF IMMUNOPROFILING IN THE SELECTION OF PATIENTS WITH COLORECTAL PERITONEAL CARCINOMATOSIS FOR CYTOREDUCTIVE SURGERY AND HEATED INTRAPERITONEAL CHEMOTHERAPY
Mary Garland-Kledzik*1, Abhineet Uppal2, Yalda Naeini3, Stacey L. Stern1, Richard A. Erali4, Anthony Scholer1, Adam Khader1, Juan A. Santamaria-Barria1, Kathleen C. Perry4, Yi Zhou4, Konstantinos I. Votanopoulos4, Perry Shen4, Edward Levine4, Anton J. Bilchik1
1General Surgery, John Wayne Cancer Institute, Santa Monica, CA; 2University of California-Irvine, Irvine, CA; 3Providence St. Johns, Santa Monica, CA; 4Wake Forest University School of Medicin, Winston Salem, NC
1043.
PREOPERATIVE HYPERCOAGULABLE THROMBOELASTOGRAPHY PROFILES ARE ASSOCIATED WITH POST-OPERATIVE VENOUS THROMBOEMBOLISM IN INFLAMMATORY BOWEL DISEASE PATIENTS
Prashansha Vaidya*, Chun Hin Angus Lee, Amy Lightner, Tracy L. Hull, Scott Steele, Stefan D. Holubar
Cleveland Clinic Colorectal Surgery, Cleveland, OH
1044.
DOES FECAL DIVERSION INDUCE A CLINICAL RESPONSE TO CROHNS DISEASE OF THE COLORECTUM?
Amy L. Lightner*1, Hassan Buhulaigah2, Karen Zaghiyan2, Prashansha Vaidya1, Miguel D. Regueiro1, Phillip Fleshner2
1Cleveland Clinic, Cleveland, OH; 2Cedars Sinai, Los Angeles, CA
1045.
DECLINING RATES OF EMERGENT SURGERY FOR INFLAMMATORY BOWEL DISEASE IN THE ERA OF BIOLOGIC THERAPY
Sarina C. Lowe*, Jenny Sauk, Berkeley N. Limketkai, Mary Kwaan
University of California, Los Angeles (UCLA), Los Angeles, CA
1046.
MULTICENTER, RANDOMIZED CONTROLLED TRIAL OF LONG TUBE VERSUS NASOGASTRIC TUBE WITH WATER-SOLUBLE CONTRAST AGENT FOR SMALL BOWEL OBSTRUCTION
Takahito Katano*1, Takaya Shimura1, Hirotada Nishie1, Tomohiro Iwai2, Keisuke Itoh3, Masahide Ebi4, Yusuke Mizuno5, Shozo Togawa6, Shunsuke Shibata2, Tomonori Yamada5, Takashi Mizushima7, Yusuke Inagaki8, Shuji Takiguchi9, Hiromi Kataoka1
1Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Please Select, Japan; 2Toyokawa City Hospital, Toyokawa, Japan; 3Nagoya City East medical Center, Nagoya, Japan; 4Aichi Medical University, Nagakute, Japan; 5Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan; 6Nagoya Memorial Hospital, Nagoya, Japan; 7Gifu Prefectural Tajimi Hospital, Tajimi, Japan; 8Gamagori City Hospital, Gamagori, Japan; 9Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
10:00 AM - 11:30 AM
S105d
QUICK SHOT SESSION: HEPATOBILIARY & PANCREAS II
1047.
ADVERSE OUTCOMES ASSOCIATED WITH COMBINED LIVER AND RECTAL RESECTIONS FOR SYNCHRONOUS RECTAL ADENOCARCINOMA AND HEPATIC METASTASIS
Konstantinos A. Zorbas*1, Vic Velanovich2, Andreas Karachristos2
1BronxCare Health System, Icahn School of Medicine at Mount Sinai, New York, NY; 2University of South Florida, Morsani College of Medicine, Tampa, FL
1048.
VASCULAR RESECTION AND RECONSTRUCTION IN HILAR CHOLANGIOCARCINOMA
Wong-Hoi She*, Tan To Cheung, Ka Wing Ma, Simon H.Y. Tsang, Wing Chiu Dai, Albert Chan, Chung Mau Lo
Surgery, The University of Hong Kong, Hong Kong, Hong Kong
1049.
FILAMIN-A EXPRESSION PREDICTS RECURRENCE OF MASS-FORMING CHOLANGIOCARCINOMA AFTER HEPATECTOMY
Martina Nebbia*, Matteo Donadon, Flavio Milana, Cristiana Soldani, Barbara Franceschini, MICHELA ANNA POLIDORO, Di Tommaso Luca, Lleo De Nalda Ana, Andrea Lania, Guido Torzilli
Department of Hepatobiliary and General Surgery, Humanitas Research Hospital & Humanitas University, Alessandria, Italy
1050.
COMPARISON OF SHORT-TERM ONCOLOGIC OUTCOMES FOR STEREOTACTIC BODY VERSUS CONVENTIONALLY FRACTIONATED RADIATION THERAPY IN RESECTED PANCREATIC ADENOCARCINOMA
Benjamin Powers*, Jessica Frakes, Pamela J. Hodul, Dae Kim, Daniel Anaya, Mokenge P. Malafa, Sarah Hoffe, Jason Fleming, Jason W. Denbo
Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, FL
1051.
TRANSIENT BILIARY FISTULA AFTER PANCREATODUODENECTOMY INCREASES RISK OF BILIARY ANASTOMOTIC STRICTURE
Thomas K. Maatman*1, Alexa J. Loncharich2, Katelyn Flick1, Rachel E. Simpson1, Eugene P. Ceppa1, Attila Nakeeb1, Trang K. Nguyen1, C. Max Schmidt1, Nicholas J. Zyromski1, Michael G. House1
1Department of Surgery, Indiana University School of Medicine, Indianapolis, IN; 2Indiana University School of Medicine, Indianapolis, IN
1052.
ONCOLOGIC OUTCOMES OF CYST-ASSOCIATED VS. CLASSICAL PANCREATIC DUCTAL ADENOCARCINOMA
Timothy E. Newhook*, Michael P. Kim, Yi-Ju Chiang, Ching-Wei Tzeng, Naruhiko Ikoma, Jean-Nicolas Vauthey, Thomas Aloia, Jeffrey E. Lee, Matthew Katz, Hop Tran Cao
Surgical Oncology, MD Anderson Cancer Center, Missouri City, TX
1053.
EFFECTS OF NEOADJUVANT THERAPY ON THE OCCURENCE OF CLINICAL RELEVANT PANCREATIC FISTULA AFTER PANCREATICODUODENECTOMY
Konstantinos A. Zorbas*1, Vic Velanovich2, Andreas Karachristos2
1BronxCare Health System, Icahn School of Medicine at Mount Sinai, New York, NY; 2University of South Florida Morsani College of Medicine, Tampa, FL
1054.
DEVELOPMENT OF A MULTIVARIABLE MODEL TO PREDICT POSITIVE SURGICAL MARGIN IN PATIENTS WITH BORDERLINE RESECTABLE AND LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Weizheng Ren*1,2, Dimitrios Xourafas1, Stanley W. Ashley1, Thomas Clancy1
1Surgery , Brigham and Women's Hospital, Boston , MA; 2Chinese PLA General Hospital, Beijing, China
1055.
SURGERY WITH CURATIVE INTENT IN OLIGOMETASTATIC PANCREATIC CANCER TO THE LIVER IN THE ERA OF FOLFIRINOX: A SYSTEMATIC REVIEW AND META-ANALYSIS
Ottavia De Simoni*1, Marco Scarpa2, Marco Tonello1, Pierluigi Pilati1, Francesca Tolin1, Ylenia Spolverato2, Mario Gruppo1
1Unit of Surgical Oncology of the Esophagus and Digestive Tract, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy; 2University Hospital of Padua, Padua, Italy
1056.
MINIMALLY INVASIVE HEPATECTOMY IN NORTH AMERICA: LAPAROSCOPIC VERSUS ROBOTIC
Alexander M. Fagenson*, Sunil S. Karhadkar, Antonio Di Carlo, Henry A. Pitt, Kwan N. Lau
Surgery, Temple University Hospital, Philadelphia, PA
1057.
LAPAROSCOPIC SURGERY FOR INTRAHEPATIC CHOLANGIOCARCINOMA: A PROPENSITY SCORE MATCHING ANALYSIS
Andrea Ruzzenente*1, Nadia Russolillo2, Fabio Bagante1, Simone Conci1, Roberto Lo Tesoriere2, Tommaso Campagnaro1, Serena Langella2, Alessandro Ferrero2, Alfredo Guglielmi1
1University of Verona Medical School, Verona, Italy; 2Department of General and Oncological Surgery, Mauriziano Hospital, Turin, Italy
1058.
GALLBLADDER CANCER: CONTEMPORARY OUTCOMES OF SURGICAL MANAGEMENT FOR ADVANCED DISEASE WITH T3 OR GREATER
Hiromichi Ito*, Atsushi Oba, Yoshihiro Ono, Takafumi Sato, Yosuke Inoue, Yu Takahashi
Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
1058.
GALLBLADDER CANCER: CONTEMPORARY OUTCOMES OF SURGICAL MANAGEMENT FOR ADVANCED DISEASE WITH T3 OR GREATER
Hiromichi Ito*, Atsushi Oba, Yoshihiro Ono, Takafumi Sato, Yosuke Inoue, Yu Takahashi
Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
1059.
VERY-EARLY RECURRENCE AFTER LIVER RESECTION FOR COLORECTAL LIVER METASTASES. IS THIS A BIOMARKER OF FUTILE SURGERY?
Damiano Gentile*, Luca Viganò, Jacopo Galvanin, Fabio Procopio, Cimino Matteo Maria, Matteo Donadon, Daniele Del Fabbro, Guido Torzilli
Department of Upper Gastro-Intestinal Surgery, Humanitas Research Hospital, Rozzano, Milano, Italy
1060.
RESECTION RATE AND SURVIVAL AFTER NEOADJUVANT THERAPY FOR BORDERLINE RESECTABLE AND LOCALLY ADVANCED PANCREATIC CANCER: A PROSPECTIVE COHORT STUDY
Simone Serafini*, Lucia Moletta, Elisa Sefora Pierobon, Alberto Ponzoni, Giovanni Capovilla, Alfredo Piangerelli, Michele Valmasoni, Cosimo Sperti
University of Padova, Padova, Italy
12:30 PM - 1:30 PM
Hall E
POSTER SESSION III (NON-CME)
 
Authors available at their posters to answer questions 12:30 PM - 2:30 PM; posters on display 9:30 AM - 4 PM.
12:00 PM - 3:00 PM
S105a
KELLY AND CARLOS PELLEGRINI SSAT/SAGES LUNCHEON SYMPOSIUM:
SURGICAL ADVANCES IN THE MANGEMENT OF REFLUX
 
Moderators: Wayne L. Hofstetter, Houston, TX
Leena Khaitan, Cleveland, OH

ADVANCES IN THE DIAGNOSIS OF REFLUX
Min Kim, Houston, TX

ENDOSCOPIC MANAGEMENT OF REFLUS: TIF, STRETTA, ARMS WHERE ARE WE NOW?
Michael Ujiki, Evanston, IL

SURGICAL OPTIONS FOR REFLUX MANAGEMENT: WHEN TO USE NISSEN, TOUPLET, LINX?
John Lipham, Los Angeles, CA

PROCEDURES ON THE HORIZON FOR REFLUX
Ralph Aye, Seattle, WA

PANEL & AUDIENCE DISCUSSION

MANAGEMENT OPTIONS FOR GERD IN OBESE PATIENTS
Anna Ibele, Salt Lake City, UT

PREOPERATIVE EVALUATION FOR GERD IN BARIATRIC SURGERY?
Marina Kurian, New York, NY

DIAGNOSIS/MANAGEMENT OF GERD AFTER SLEEVE GASTRECTOMY
Leena Khaitan, Cleveland, OH

PERSISTENT REFLUX AFTER RNY: CAUSES AND MANAGEMENT STRATEGIES
Aurora Pryor, Centereach, NY

PANEL & AUDIENCE DISCUSSION
2:00 PM - 4:00 PM
S100c
BEST OF DDW 2020 (NON-CME)
 
Discussants from the SSAT, AASLD, AGA, and ASGE will review their societies' top presentations; attend this session to get an overview of the latest, best, and most thought-provoking research presented all week. Consult MyDDW for the schedule of expert critiques.

<<Monday | Program and Abstracts